Inventia Healthcare’s chlorthalidone recall is drawing attention after the FDA assigned it a Class II classification. Learn about the dissolution testing issue and affected tablets.
Discover more from NAIRAVOICE.COM.NG
Subscribe to get the latest posts sent to your email.
Enjoying this article? Support our work with a small crypto donation.
Enjoyed this? A small crypto donation helps us keep publishing.
